SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-170652
Filing Date
2017-05-15
Accepted
2017-05-15 16:11:54
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d383725d10q.htm 10-Q 284720
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d383725dex311.htm EX-31.1 6262
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d383725dex312.htm EX-31.2 6245
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 PRINCIPAL EXECUTIVE OFFICER d383725dex321.htm EX-32.1 2837
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 CHIEF FINANCIAL OFFICER d383725dex322.htm EX-32.2 2802
  Complete submission text file 0001193125-17-170652.txt   2090056

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20170331.xml EX-101.INS 243692
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20170331.xsd EX-101.SCH 35035
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20170331_cal.xml EX-101.CAL 29880
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20170331_def.xml EX-101.DEF 121278
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20170331_lab.xml EX-101.LAB 281390
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20170331_pre.xml EX-101.PRE 188331
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 17844306
SIC: 2834 Pharmaceutical Preparations